Active Biotech Investor Relations Material
Latest events
Investor Update
Active Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Active Biotech
Access all reports
Active Biotech AB is a Swedish biotechnology company focused on developing treatments for cancer and inflammatory diseases. Its key projects include Tasquinimod, an immunomodulatory molecule in clinical trials for multiple myeloma and myelofibrosis, and Laquinimod, aimed at treating inflammatory eye disorders like uveitis. Additionally, Naptumomab, an antibody-based immunotherapy, is being tested in combination with other treatments for solid tumors, including non-small cell lung cancer. The company is headquartered in Lund, Sweden, and is listed on the Nasdaq Stockholm.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ACTI
Country
🇸🇪 Sweden